Jacob Elizabeth, Avery Amanda
Faculty of Science The University of Nottingham Nottingham UK.
Obes Sci Pract. 2021 May 15;7(5):606-618. doi: 10.1002/osp4.504. eCollection 2021 Oct.
Type 2 diabetes (T2D) is a chronic, progressive disease. Caloric restriction and subsequent weight loss have been associated with both improvements and, in some cases, remission of T2D.
To systematically review the safety and effectiveness of calorie-restricted diets on weight change and the remission of T2D.
Electronic databases were searched. Intervention trials including a calorie restriction, published between 2010 and 2020, evaluating the remission of T2D (HbA1c <6.5% without diabetes medication) were selected. Risk of bias was assessed.
Eight trials met inclusion criteria including four randomized controlled and four single-arm trials. Three controlled trials found greater remission in the calorie-restricted arm ( < 0.05). A recent diagnosis of diabetes was associated with higher remission rates (75%-80%) with an inverse association between duration of diabetes and rate of remission ( = -0.94). A higher level of remission was observed with greater calorie restriction in non-new diagnosis studies. Greater weight loss was associated with increasing rates of remission ( = 0.83). No reported adverse events led to withdrawal from trials. There was great heterogeneity in study design.
Remission rate of T2D achieved through calorie restriction is high and similar to that reported in the bariatric surgery literature. Remission should be the aim at diagnosis and calorie restriction could be used to achieve this. The target weight loss should be >10% body weight in people with obesity. More research is needed into the optimum level of calorie restriction and the support required for long-term remission. National guidelines should be updated to reflect recent evidence.
2型糖尿病(T2D)是一种慢性进展性疾病。热量限制及随后的体重减轻与T2D的改善及某些情况下的缓解相关。
系统评价热量限制饮食对体重变化及T2D缓解的安全性和有效性。
检索电子数据库。选择2010年至2020年间发表的包括热量限制的干预试验,评估T2D的缓解情况(糖化血红蛋白<6.5%且未使用糖尿病药物)。评估偏倚风险。
八项试验符合纳入标准,包括四项随机对照试验和四项单臂试验。三项对照试验发现热量限制组的缓解率更高(P<0.05)。糖尿病近期诊断与较高的缓解率相关(75%-80%),糖尿病病程与缓解率呈负相关(r=-0.94)。在非新诊断研究中,热量限制程度越高,缓解水平越高。体重减轻越多,缓解率越高(r=0.83)。没有报告的不良事件导致试验退出。研究设计存在很大异质性。
通过热量限制实现的T2D缓解率很高,与减肥手术文献报道的相似。缓解应作为诊断时的目标,热量限制可用于实现这一目标。肥胖人群的目标体重减轻应>10%体重。需要更多关于热量限制最佳水平和长期缓解所需支持的研究。国家指南应更新以反映最新证据。